FDA approves Novoste's 40mm Beta-Cath device:
This article was originally published in Clinica
The US FDA has approved Novoste's PMA supplement application for a longer version of its Beta-Cath coronary radiation system. The device, previously available with a 30mm radiation source train, can now be sold with a 40mm radiation source, says the Atlanta, Georgia firm. Both versions of the device are indicated for the treatment of in-stent restenosis.